Real Chemistry, a UK-based healthcare industry organisation, has appointed two high-profile figures to its Board of Directors. Frank Clyburn, a seasoned executive with a strong background in commercialisation and business development, joins the Board, alongside Chris Fikry, who brings extensive experience in data-driven transformation and growth.
The appointments were made to strengthen Real Chemistry's leadership and drive growth in the UK healthcare industry. The organisation, which provides a range of services, including market research, data analysis, and consulting, operates in a highly competitive and rapidly evolving market.
The new directors will play a crucial role in shaping the organisation's strategy and driving its growth agenda. Their expertise will be invaluable in navigating the complexities of the UK healthcare industry and identifying new opportunities for growth.
Real Chemistry's Board of Directors now comprises a diverse group of experienced professionals, each bringing their unique skills and expertise to the table. The appointments are a testament to the organisation's commitment to excellence and its ambition to become a leading player in the UK healthcare industry.